Single-cell transcriptome sequencing (scRNA-seq) is currently the most widely used single-cell sequencing technology. It performs reverse transcription, amplification and high-throughput sequencing of the mRNA of a single cell. According to the transcription profile Similarities can distinguish different cell types and even reveal new cell types.
The global Single-cell Transcriptome Sequencing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淪ingle-cell Transcriptome Sequencing Industry Forecast鈥� looks at past sales and reviews total world Single-cell Transcriptome Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Single-cell Transcriptome Sequencing sales for 2023 through 2029. With Single-cell Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single-cell Transcriptome Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Single-cell Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Single-cell Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Single-cell Transcriptome Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single-cell Transcriptome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single-cell Transcriptome Sequencing.
United States market for Single-cell Transcriptome Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Single-cell Transcriptome Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Single-cell Transcriptome Sequencing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Single-cell Transcriptome Sequencing players cover Aksomics, 10x Genomics, BD, BGI, Singleron Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Single-cell Transcriptome Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Equipment
Serve
Segmentation by Application:
Cancer
Immunology
Neurology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Equipment
Serve
Segmentation by Application:
Cancer
Immunology
Neurology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aksomics
10x Genomics
BD
BGI
Singleron Bio
Seekgene
ThunderBio
Tenk Genomics
MobiDrop
BioMarker
Dynamic Biosystems
M20 Genomics
Illumina
QIAGEN
Q2 Solutions
Novogene
Oxford Nanopore Technologies
PacBio
Azenta Life Sciences
Jingxin Biotechnology
TaKaRa
Bio-Rad
Mission bio
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Single-cell Transcriptome Sequencing 麻豆原创 Size 2019-2030
2.1.2 Single-cell Transcriptome Sequencing 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Single-cell Transcriptome Sequencing by Country/Region, 2019, 2023 & 2030
2.2 Single-cell Transcriptome Sequencing Segment by Type
2.2.1 Equipment
2.2.2 Serve
2.3 Single-cell Transcriptome Sequencing 麻豆原创 Size by Type
2.3.1 Single-cell Transcriptome Sequencing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Single-cell Transcriptome Sequencing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Single-cell Transcriptome Sequencing Segment by Application
2.4.1 Cancer
2.4.2 Immunology
2.4.3 Neurology
2.4.4 Others
2.5 Single-cell Transcriptome Sequencing 麻豆原创 Size by Application
2.5.1 Single-cell Transcriptome Sequencing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Single-cell Transcriptome Sequencing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Single-cell Transcriptome Sequencing 麻豆原创 Size by Player
3.1 Single-cell Transcriptome Sequencing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Single-cell Transcriptome Sequencing Revenue by Player (2019-2024)
3.1.2 Global Single-cell Transcriptome Sequencing Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Single-cell Transcriptome Sequencing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Single-cell Transcriptome Sequencing by Region
4.1 Single-cell Transcriptome Sequencing 麻豆原创 Size by Region (2019-2024)
4.2 Global Single-cell Transcriptome Sequencing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Single-cell Transcriptome Sequencing 麻豆原创 Size Growth (2019-2024)
4.4 APAC Single-cell Transcriptome Sequencing 麻豆原创 Size Growth (2019-2024)
4.5 Europe Single-cell Transcriptome Sequencing 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Single-cell Transcriptome Sequencing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Single-cell Transcriptome Sequencing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Single-cell Transcriptome Sequencing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single-cell Transcriptome Sequencing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Single-cell Transcriptome Sequencing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Single-cell Transcriptome Sequencing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Single-cell Transcriptome Sequencing 麻豆原创 Size by Country (2019-2024)
7.2 Europe Single-cell Transcriptome Sequencing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Single-cell Transcriptome Sequencing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Single-cell Transcriptome Sequencing by Region (2019-2024)
8.2 Middle East & Africa Single-cell Transcriptome Sequencing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Single-cell Transcriptome Sequencing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Single-cell Transcriptome Sequencing 麻豆原创 Forecast
10.1 Global Single-cell Transcriptome Sequencing Forecast by Region (2025-2030)
10.1.1 Global Single-cell Transcriptome Sequencing Forecast by Region (2025-2030)
10.1.2 Americas Single-cell Transcriptome Sequencing Forecast
10.1.3 APAC Single-cell Transcriptome Sequencing Forecast
10.1.4 Europe Single-cell Transcriptome Sequencing Forecast
10.1.5 Middle East & Africa Single-cell Transcriptome Sequencing Forecast
10.2 Americas Single-cell Transcriptome Sequencing Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.2.2 Canada 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.2.3 Mexico 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.2.4 Brazil 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.3 APAC Single-cell Transcriptome Sequencing Forecast by Region (2025-2030)
10.3.1 China Single-cell Transcriptome Sequencing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.3.3 Korea 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.3.4 Southeast Asia 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.3.5 India 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.3.6 Australia 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.4 Europe Single-cell Transcriptome Sequencing Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.4.2 France 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.4.3 UK 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.4.4 Italy 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.4.5 Russia 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.5 Middle East & Africa Single-cell Transcriptome Sequencing Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.5.2 South Africa 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.5.3 Israel 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.5.4 Turkey 麻豆原创 Single-cell Transcriptome Sequencing Forecast
10.6 Global Single-cell Transcriptome Sequencing Forecast by Type (2025-2030)
10.7 Global Single-cell Transcriptome Sequencing Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Single-cell Transcriptome Sequencing Forecast
11 Key Players Analysis
11.1 Aksomics
11.1.1 Aksomics Company Information
11.1.2 Aksomics Single-cell Transcriptome Sequencing Product Offered
11.1.3 Aksomics Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Aksomics Main Business Overview
11.1.5 Aksomics Latest Developments
11.2 10x Genomics
11.2.1 10x Genomics Company Information
11.2.2 10x Genomics Single-cell Transcriptome Sequencing Product Offered
11.2.3 10x Genomics Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 10x Genomics Main Business Overview
11.2.5 10x Genomics Latest Developments
11.3 BD
11.3.1 BD Company Information
11.3.2 BD Single-cell Transcriptome Sequencing Product Offered
11.3.3 BD Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 BD Main Business Overview
11.3.5 BD Latest Developments
11.4 BGI
11.4.1 BGI Company Information
11.4.2 BGI Single-cell Transcriptome Sequencing Product Offered
11.4.3 BGI Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 BGI Main Business Overview
11.4.5 BGI Latest Developments
11.5 Singleron Bio
11.5.1 Singleron Bio Company Information
11.5.2 Singleron Bio Single-cell Transcriptome Sequencing Product Offered
11.5.3 Singleron Bio Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Singleron Bio Main Business Overview
11.5.5 Singleron Bio Latest Developments
11.6 Seekgene
11.6.1 Seekgene Company Information
11.6.2 Seekgene Single-cell Transcriptome Sequencing Product Offered
11.6.3 Seekgene Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Seekgene Main Business Overview
11.6.5 Seekgene Latest Developments
11.7 ThunderBio
11.7.1 ThunderBio Company Information
11.7.2 ThunderBio Single-cell Transcriptome Sequencing Product Offered
11.7.3 ThunderBio Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 ThunderBio Main Business Overview
11.7.5 ThunderBio Latest Developments
11.8 Tenk Genomics
11.8.1 Tenk Genomics Company Information
11.8.2 Tenk Genomics Single-cell Transcriptome Sequencing Product Offered
11.8.3 Tenk Genomics Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Tenk Genomics Main Business Overview
11.8.5 Tenk Genomics Latest Developments
11.9 MobiDrop
11.9.1 MobiDrop Company Information
11.9.2 MobiDrop Single-cell Transcriptome Sequencing Product Offered
11.9.3 MobiDrop Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 MobiDrop Main Business Overview
11.9.5 MobiDrop Latest Developments
11.10 BioMarker
11.10.1 BioMarker Company Information
11.10.2 BioMarker Single-cell Transcriptome Sequencing Product Offered
11.10.3 BioMarker Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 BioMarker Main Business Overview
11.10.5 BioMarker Latest Developments
11.11 Dynamic Biosystems
11.11.1 Dynamic Biosystems Company Information
11.11.2 Dynamic Biosystems Single-cell Transcriptome Sequencing Product Offered
11.11.3 Dynamic Biosystems Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Dynamic Biosystems Main Business Overview
11.11.5 Dynamic Biosystems Latest Developments
11.12 M20 Genomics
11.12.1 M20 Genomics Company Information
11.12.2 M20 Genomics Single-cell Transcriptome Sequencing Product Offered
11.12.3 M20 Genomics Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 M20 Genomics Main Business Overview
11.12.5 M20 Genomics Latest Developments
11.13 Illumina
11.13.1 Illumina Company Information
11.13.2 Illumina Single-cell Transcriptome Sequencing Product Offered
11.13.3 Illumina Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Illumina Main Business Overview
11.13.5 Illumina Latest Developments
11.14 QIAGEN
11.14.1 QIAGEN Company Information
11.14.2 QIAGEN Single-cell Transcriptome Sequencing Product Offered
11.14.3 QIAGEN Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 QIAGEN Main Business Overview
11.14.5 QIAGEN Latest Developments
11.15 Q2 Solutions
11.15.1 Q2 Solutions Company Information
11.15.2 Q2 Solutions Single-cell Transcriptome Sequencing Product Offered
11.15.3 Q2 Solutions Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Q2 Solutions Main Business Overview
11.15.5 Q2 Solutions Latest Developments
11.16 Novogene
11.16.1 Novogene Company Information
11.16.2 Novogene Single-cell Transcriptome Sequencing Product Offered
11.16.3 Novogene Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Novogene Main Business Overview
11.16.5 Novogene Latest Developments
11.17 Oxford Nanopore Technologies
11.17.1 Oxford Nanopore Technologies Company Information
11.17.2 Oxford Nanopore Technologies Single-cell Transcriptome Sequencing Product Offered
11.17.3 Oxford Nanopore Technologies Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Oxford Nanopore Technologies Main Business Overview
11.17.5 Oxford Nanopore Technologies Latest Developments
11.18 PacBio
11.18.1 PacBio Company Information
11.18.2 PacBio Single-cell Transcriptome Sequencing Product Offered
11.18.3 PacBio Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 PacBio Main Business Overview
11.18.5 PacBio Latest Developments
11.19 Azenta Life Sciences
11.19.1 Azenta Life Sciences Company Information
11.19.2 Azenta Life Sciences Single-cell Transcriptome Sequencing Product Offered
11.19.3 Azenta Life Sciences Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Azenta Life Sciences Main Business Overview
11.19.5 Azenta Life Sciences Latest Developments
11.20 Jingxin Biotechnology
11.20.1 Jingxin Biotechnology Company Information
11.20.2 Jingxin Biotechnology Single-cell Transcriptome Sequencing Product Offered
11.20.3 Jingxin Biotechnology Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Jingxin Biotechnology Main Business Overview
11.20.5 Jingxin Biotechnology Latest Developments
11.21 TaKaRa
11.21.1 TaKaRa Company Information
11.21.2 TaKaRa Single-cell Transcriptome Sequencing Product Offered
11.21.3 TaKaRa Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 TaKaRa Main Business Overview
11.21.5 TaKaRa Latest Developments
11.22 Bio-Rad
11.22.1 Bio-Rad Company Information
11.22.2 Bio-Rad Single-cell Transcriptome Sequencing Product Offered
11.22.3 Bio-Rad Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 Bio-Rad Main Business Overview
11.22.5 Bio-Rad Latest Developments
11.23 Mission bio
11.23.1 Mission bio Company Information
11.23.2 Mission bio Single-cell Transcriptome Sequencing Product Offered
11.23.3 Mission bio Single-cell Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.23.4 Mission bio Main Business Overview
11.23.5 Mission bio Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
